Showing results (21-30 of 28) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Aging and Disease|May 13, 2024
Inferior Frontal Sulcal Hyperintensity on Fluid-Attenuated Inversion Recovery Is Related to Cerebrospinal Fluid Clearance via Putative Meningeal LymphaticsZiyu Zhou, Ying Zhou, Wang Ran, et al.European Journal of Radiology|February 22, 2023
Impaired intracranial venous outflow profiles are associated with poor outcome in stroke after reperfusion therapy: A hypoperfusion-matched intracranial venous scaleRuoxia Zhang, Shenqiang Yan, Wansi Zhong, et al.Translational Stroke Research|September 8, 2020
Iodinated Contrast Agents Reduce the Efficacy of Intravenous Recombinant Tissue-Type Plasminogen Activator in Acute Ischemic Stroke Patients: a Multicenter Cohort StudyZhicai Chen, Chao Xu, Wansi Zhong, et al.Annals of Neurology|March 27, 2023
Choroid Plexus Enlargement Exacerbates White Matter Hyperintensity Growth through Glymphatic ImpairmentYifei Li, Ying Zhou, Wansi Zhong, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|May 5, 2024
Impaired Meningeal Lymphatics and Glymphatic Pathway in Patients with White Matter HyperintensityYing Zhou, Rui Xue, Yifei Li, et al.Journal of Neurology, Neurosurgery, and Psychiatry|April 27, 2022
Stroke outcome of early antiplatelet in post-thrombolysis haemorrhagic infarctionWansi Zhong, Shenqiang Yan, Zhicai Chen, et al.Stroke and Vascular Neurology|August 1, 2023
Treatment with intravenous alteplase in ischaemic stroke patients with onset time between 4.5 and 24 hours (HOPE): protocol for a randomised, controlled, multicentre studyZhongyu Luo, Ying Zhou, Yaode He, et al.JAMA|August 7, 2025
Alteplase for Acute Ischemic Stroke at 4.5 to 24 Hours: The HOPE Randomized Clinical TrialYing Zhou, Yaode He, Bruce C V Campbell, et al.Pageof 3